This is a routine reaffirmation with zero new information. Monitor the next quarterly earnings release (Q2 2026) for any updates to revenue and EPS trajectory. No immediate trading catalyst.
Price Chart
Executive Summary
Ionis Pharmaceuticals filed an 8-K reaffirming its previously announced FY2026 financial guidance from April 29, 2026, with no changes. The filing contains no new financial data, preliminary results, or material updates — only a confirmation of prior guidance.
Key Facts
- Ionis reaffirms previously announced FY2026 financial guidance unchanged from April 29, 2026 Q1 earnings release
- No new financial metrics, preliminary results, or guidance revisions disclosed
- Filing contains only a brief Regulation FD disclosure with forward-looking statements
Financial Impact
No new financial data disclosed; guidance unchanged from prior guidance (amounts not republished in this filing)
Risk Factors
- No new information reduces near-term volatility; stock may drift with sector
- Forward-looking statements subject to clinical and regulatory risks in Ionis' pipeline
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-028154 |
| Document: 0001140361-26-028154-index-headers.html | 0001140361-26-028154 |
| Document: 0001140361-26-028154-index.html | 0001140361-26-028154 |
| Document: 0001140361-26-028154.txt | 0001140361-26-028154 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 27d ago | 8-K | $56.71 $47.25 | ▲ +16.68% | ▲ +15.56% | $43.54 (+23.22%) |
Sep 4, 2026 28d ago | 8-K | $58.09 $51.44 | ▼ −11.45% | ▼ −10.24% | $43.54 (−25.05%) |
Jul 31, 2026 9w ago | Insider Buy | $51.77 $56.56 | ▲ +9.25% | ▲ +5.74% | $43.54 (−15.90%) |
Jul 29, 2026 9w ago | 8-K | $54.04 $54.19 | ▲ +0.28% | ▼ −5.25% | $43.54 (−19.43%) |
Jul 10, 2026 12w ago | 8-K | $58.25 $54.65 | ▼ −6.18% | ▼ −5.62% | $43.54 (−25.25%) |
Jul 9, 2026 12w ago | Insider Cluster | $58.25 $54.65 | ▼ −6.18% | ▼ −5.62% | $43.54 (−25.25%) |
Jul 9, 2026 12w ago | Insider Cluster | $58.25 $54.65 | ▼ −6.18% | ▼ −5.62% | $43.54 (−25.25%) |
Jul 9, 2026 12w ago | 8-K | $64.27 $54.65 | ▲ +14.97% | ▲ +14.84% | $43.54 (+32.25%) |
Jun 30, 2026 13w ago | Insider Cluster | $79.19 $86.33 | ▲ +9.02% | ▲ +8.75% | $43.54 (−45.02%) |
Jun 30, 2026 13w ago | Insider Cluster | $79.19 $86.33 | ▲ +9.02% | ▲ +8.75% | $43.54 (−45.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access